Noninvasive cervical cancer complicating pregnancy

Area of Science:

• Obstetrics and Gynecology
• Oncology
• Cervical Pathology

Background:

• Management of abnormal cervical cytology during pregnancy has evolved significantly over 30 years.
• The primary goal is timely diagnosis and treatment planning for invasive cervical cancer.
• Preinvasive cervical intraepithelial neoplasia (CIN) treatment can be safely deferred postpartum.

Purpose of the Study:

• To evaluate the safety and accuracy of conservative management for abnormal cervical cytology in pregnancy.
• To assess the impact of colposcopy and biopsy in distinguishing CIN from invasive cervical cancer.
• To reduce the need for cone biopsy during pregnancy due to its associated morbidity.

Main Methods:

• Review of data on colposcopy and biopsy for abnormal cervical cytology in pregnant patients.
• Comparison of outcomes between conservative management (colposcopy/biopsy) and cone biopsy.
• Analysis of postpartum evaluation results following conservative management.

Main Results:

• Colposcopy and biopsy demonstrate safety and accuracy in diagnosing cervical conditions during pregnancy.
• The diligent application of colposcopy has significantly reduced the necessity of cone biopsies.
• Cone biopsies during pregnancy are often not therapeutic, with high rates of positive margins and residual disease.

Conclusions:

• Conservative management with colposcopy and biopsy is effective for abnormal cervical cytology in pregnancy.
• Postponing treatment for CIN until postpartum is a safe and accurate strategy.
• Postpartum reevaluation is crucial to ensure complete resolution of cervical disease.